Sanara MedTech Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026

Core Viewpoint - Sanara MedTech Inc. will report its fourth quarter and full year 2025 financial results on March 24, 2026, before U.S. financial markets open [1] Group 1: Financial Reporting - The company will host a conference call and webcast on March 24, 2026, at 8:00 a.m. Eastern Time to discuss the financial results and hold a Q&A session [2] - A telephonic replay of the conference call will be available until April 7, 2026 [2] Group 2: Company Overview - Sanara MedTech Inc. focuses on developing and commercializing transformative technologies aimed at improving clinical outcomes and reducing healthcare costs in the surgical market [4] - The company markets and distributes various surgical products, including CellerateRX Surgical Activated Collagen Powder and FORTIFY TRG Tissue Repair Graft, primarily in the North American surgical tissue repair market [4] - Sanara aims to be an innovative provider of effective surgical solutions and is continually seeking to expand its offerings for patients in the United States [4]